Table 8.
Pathological characteristics of cancers with ESD indication but with lymph node metastasis.
| Pathological type | Age | Sex | Size | Infiltration depth | Pure/mixed | Macroscopic type |
|---|---|---|---|---|---|---|
| SRCC | 54 | F | 0.9×0.5×0.3 | Intramucosal | Pure | IIc |
| SRCC | 66 | F | 1.5×1×0.5 | Intramucosal | Pure | IIb |
| PDC | 64 | M | 2×0.8×0.2 | Intramucosal | Mixed | IIb |
| PDC | 50 | M | 0.8×0.7×0.4 | Intramucosal | Pure | IIc |
| PDC | 58 | F | 1.2×1.0×0.3 | Intramucosal | Mixed | IIc |
| PDC | 61 | F | 1.8×0.6×0.2 | Intramucosal | Mixed | IIc |
| PDC | 54 | M | 1.0×1.0×0.2 | Intramucosal | Mixed | IIc |
| PDC | 57 | M | 0.9×0.9×0.3 | Intramucosal | Mixed | IIc |
| PDC | 58 | F | 1.5×1.0×0.2 | Intramucosal | Mixed | IIc |
| PDC | 64 | M | 2.0×2.0×0.3 | Intramucosal | Mixed | IIc |
ESD, endoscopic submucosal dissection; PDC, poorly differentiated carcinoma; SRCC, signet ring cell carcinoma.